Beth Lindborg is the CEO of Sarcio Inc. The company is developing a cartilage cell therapy to treat patients and free them from the devastating effects of Osteoarthritis by restoring, regenerating, and repairing joints.

She previously served as vice president of strategy and, before that, vice president of operations at SynerFuse, Inc., where the company raised more than $7 million in angel funding and received IDE approval from the FDA for its first-in-human clinical trial. She also served as director of research and marketing at BRTI Life Sciences, where the company launched two products in the life science market.

Beth completed her Master of Science in Molecular, Cellular, Developmental Biology, and Genetics at the University of Minnesota in 2006 and her Master’s in Business Administration at the University of Minnesota Carlson School of Management in 2012.

Past Event

Note: Speaker biographies were written at time of speaking engagement and may not reflect their current job title and position.
View All
Connect With Beth